Ingabe Kuyafaneleka Ukuba Izingane Zisebenzise Le Mithi?
I-Singulair imithi yokwelapha imithi yokwelashwa engasetshenziselwa ukwelapha i-rhinitis ye-allergen noma i-allergies yangaphakathi ezinganeni ezincane ezineminyaka eyisithupha ubudala kanye ne-rhinitis ye-allergic noma i-allergies yangaphandle ezinganeni ezingaphezu kweminyaka engu-2. Ingasiza ekulawuleni zonke izimpawu zokugula ezinganeni yakho , kufaka phakathi ukukhipha, ukuphumula, impumu egijima, nekhala elimnandi.
Lokho okushiwo yi-Singulair
I-Singulair isetshenziselwa ukuphatha izingane ezinomzimba ongaphakathi nangaphandle. Ngokungafani neminye imithi yokwelashwa, njengeClarinex neZyrtec, i-Singulair nayo ivunyiwe ukusiza ukulawula i- asthma kubantwana .
Amafomu we-Singulair afaka ama-Singulair Oral Granules (iminyaka engu-6 kuya eminyakeni engu-5), amathebulethi angama-Singulair angama-4mg (iminyaka emibili kuya kweyesi-5), amathebhulethi a-Singulair atholakalayo 5 mg (iminyaka engama-6 kuya kwengu-14) kanye namathebulethi e-Singulair 10 mg (aneminyaka engu-15 nangaphezulu ).
Izingoma ze-Singulair
I-Montelukast sodium, i-leukotriene receptor antagonist, iyisithako esisebenzayo ku-Singulair. Ama-leukotrienes acatshangwa ukuthi abangela izimpawu eziningi zokungezwani komzimba nezifo ze-asthma ngakho-ke ukuvimbela nabo nge-Singulair kungasiza ukulawula izimpawu zomntanakho.
I-Singulair iza njengama-granules omlomo angafafazwa nge-appleauce futhi njengethebhulethi ephathekayo, okwenze kube lula ukunikeza izingane ezincane ezingakwazi ukugwinya amaphilisi futhi ngeke ziphuze umuthi wezokwelapha ophuzayo.
I-Singulair ingathathwa kanye kuphela ngosuku, kepha izingane ezine-asthma kufanele zithathe i-Singulair yazo kusihlwa. Izingane ezinezinambuzane, noma kunjalo, zingayithatha noma nini lapho kungenzeka, kepha cishe cishe ngesikhathi esifanayo usuku ngalunye.
Ama-Singulair Oral Granules angancibilika epasipuni lesifiso sesana noma ubisi lwebele noma okuxubile (njengoba kushiwo ngenhla) nge-spoonful of baby soft, okufana nama-appleauce, izaqathe, irayisi, noma i-ayisikhilimu, noma ufake ngqo emlonyeni wengane yakho.
Imiphumela ye-Singulair Side Side
I-Singulair ivame ukubekezelela kahle izingane. Imiphumela emibi kakhulu ehlanganisa ubuhlungu besisu, isisu noma ukukhulelwa emathunjini, ukushisa isisu, ukukhathala, umkhuhlane, ukuphuza, ukukhwehlela, umkhuhlane, ukutheleleka okuphezulu kokuphefumula, isizungu, ukukhanda ikhanda nokukhwabanisa.
Imiphumela emibi engavamile ehlanganisa ukuhlukumeza nokuziphatha okunonya, ukuphikisana kwemizwa, ukuvuthwa kanye nokushaya, amaphupho amabi noma acacile, ukunyuka kwegazi okukhuphuka, ukulimaza, ukuhuda, ukulala, ukucubungula, ukushisa kwesifo sofuba, ukuguquka, ukushaywa umoya, ukucasula, ubuhlungu obuhlangene, imisipha yomzimba nemisipha yomzimba , isicashu, izintambo, izikhonkwane nezinaliti / ukungabi namandla, ukuphumula, ukuhlupha, ukuvuvukala, ukukhathazeka ukulala nokuhlanza.
Futhi, i-FDA ikhishwe 'ukukhulumisana kokuqala' mayelana "nokuhlangana okungenzeka phakathi kokusetshenziswa kwe-Singulair nokuguquka kokuziphatha / kwemizwelo, ukuzibulala (ukuzibulala nokuzibulala) nokuzibulala."
Okudingeka Ukwazi
Ngokungafani nama-antihistamine amaningi, yiziphi ezinye izinhlobo zemithi ezisetshenziselwa ukwelapha izingane ezinezifo, i-Singulair ayibangeli ukulala noma ukuguqulwa, okuyinto engayenza imithi emihle yokungezwani komzimba yabantwana abaye balala noZyrtec, Claritin, noma uClarinex .
Qinisekisa ukuthi utshele udokotela wakho ngokushesha uma ingane yakho ithatha i-Singulair ithola umuzwa wezikhonkwane nezinaliti noma ukuphazamiseka kwezingalo noma imilenze yakhe, ukugula okufana nokukhuhlane, ukuqhuma, noma ubuhlungu obukhulu nokuvuvukala kwezono zakhe.
Olunye Ulwazi Olubalulekile Nge-Singulair
Izingane akufanele zithathe i-Singulair ngokusizwa ngokushesha kokuhlasela kwe- asthma , esikhundleni sokusindisa i-inhaler esikhundleni sayo. Izingane kanye nabantu abadala bangathatha i-Singulair noma ngaphandle kokudla.
Izinkomba:
I-Singulair Echaza Imininingwane Yokwaziswa. Mashi 2008.
I-Singulair yePatient Information Sheet Sheet. Novemba 2005.